Streetbeat News

Earnings

AMPH

Amphastar Pharma reported Q3 adjusted earnings of $1.15 per share, beating the analyst consensus estimate of $0.69 by 66.67%. This is a 202.63% increase from the same period last year. The company also reported quarterly sales of $180.56 million, beating the analyst consensus estimate of $174.63 million by 3.39%. This is a 50.30% increase from the same period last year.

Portfolio Pulse from Benzinga Newsdesk

November 08, 2023 | 9:46 pm

LVLU

Lulus Fashion Lounge (NASDAQ:LVLU) reported Q3 losses of $(0.10) per share, missing the analyst consensus estimate of $(0.06) by 66.67%. The company also reported quarterly sales of $83.12 million, missing the estimate of $86.29 million by 3.68%. This represents a 600% decrease in earnings and a 21.05% decrease in sales compared to the same period last year.

Portfolio Pulse from totan@benzinga.com

November 08, 2023 | 9:45 pm

PSEC

Prospect Capital (NASDAQ:PSEC) reported its Q1 earnings results, beating estimated earnings by 47.62% with an EPS of $0.31 versus an estimate of $0.21. Revenue was up $33.57 million from the same period last year. Last quarter, the company also beat EPS estimates, which was followed by a 0.5% increase in the share price the next day.

Portfolio Pulse from Benzinga Insights

November 08, 2023 | 9:45 pm

AKYA

Akoya Biosciences (NASDAQ:AKYA) reported its Q3 earnings, beating estimated earnings by 29.73% with an EPS of $-0.26 versus an estimate of $-0.37. Revenue was up $6.36 million from the same period last year. Last quarter, the company missed on EPS by $0.07, which was followed by a 3.01% increase in the share price the next day.

Portfolio Pulse from Benzinga Insights

November 08, 2023 | 9:45 pm

VNDA

Vanda Pharma (NASDAQ:VNDA) reported its Q3 earnings, missing estimated earnings by 100.0% with an EPS of $0.0 versus an estimate of $-0.04. Revenue was down $26.50 million from the same period last year. Last quarter, the company beat on EPS by $0.16, which was followed by a 8.05% drop in the share price the next day.

Portfolio Pulse from Benzinga Insights

November 08, 2023 | 9:45 pm

PAHC

Phibro Animal Health has projected its net sales for FY24 to be between $980 million and $1.02 billion.

Portfolio Pulse from Benzinga Newsdesk

November 08, 2023 | 9:45 pm

RBT

Rubicon reported Q3 2023 earnings per share (EPS) of $(0.85), beating the estimate of $(1.24). However, the company's revenue of $171.3M fell short of the $175.98M estimate.

Portfolio Pulse from Benzinga Newsdesk

November 08, 2023 | 9:45 pm

MVIS

Microvision (NASDAQ:MVIS) reported its Q3 earnings, missing estimated earnings by 33.33% with an EPS of $-0.12 versus an estimate of $-0.09. However, revenue was up $1.05 million from the same period last year. Last quarter, a miss on EPS led to a 10.33% drop in the share price the next day.

Portfolio Pulse from Benzinga Insights

November 08, 2023 | 9:45 pm

HLTH

Cue Health (NASDAQ:HLTH) reported its Q3 earnings, beating estimated earnings by 6.67% with an EPS of $-0.42 versus an estimate of $-0.45. However, revenue was down $52.11 million from the same period last year. Last quarter, the company missed on EPS by $0.01, which was followed by a 4.55% drop in the share price the next day.

Portfolio Pulse from Benzinga Insights

November 08, 2023 | 9:45 pm

SPNT

SiriusPoint (NYSE:SPNT) reported its Q3 earnings, beating estimated earnings by 60.0% with an EPS of $0.32 versus an estimate of $0.2. Revenue was up $15.50 million from the same period last year. Last quarter, the company also beat EPS estimates, which was followed by a 7.71% increase in the share price the next day.

Portfolio Pulse from Benzinga Insights

November 08, 2023 | 9:45 pm